IMM-47
- Generic Name
- IMM-47
A Study Of IMM47 In Subjects With Advanced Solid Tumors
- First Posted Date
- 2023-08-14
- Last Posted Date
- 2023-10-04
- Lead Sponsor
- ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT05985083
- Locations
- 🇦🇺
Scientia Clinical Research Ltd, NSW, Sydney, New South Wales, Australia
🇦🇺Icon Cancer Centre South Brisbane, QLD, Brisbane, Queensland, Australia
🇦🇺John Flynn Private Hospital, Gold Coast, Queensland, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath